Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Reverse Genetics Approaches for the Development of Influenza Vaccines.

Nogales A, Martínez-Sobrido L.

Int J Mol Sci. 2016 Dec 22;18(1). pii: E20. doi: 10.3390/ijms18010020. Review.

2.

Replication-Competent Influenza A Viruses Expressing Reporter Genes.

Breen M, Nogales A, Baker SF, Martínez-Sobrido L.

Viruses. 2016 Jun 23;8(7). pii: E179. doi: 10.3390/v8070179. Review.

3.

Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia.

Ito T, Itakura J, Takahashi S, Sato M, Mino M, Fushimi S, Yamada M, Morishima T, Kunkel SL, Matsukawa A.

Crit Care Med. 2016 Jul;44(7):e530-43. doi: 10.1097/CCM.0000000000001562.

PMID:
26757161
4.

Replication-competent fluorescent-expressing influenza B virus.

Nogales A, Rodríguez-Sánchez I, Monte K, Lenschow DJ, Perez DR, Martínez-Sobrido L.

Virus Res. 2016 Feb 2;213:69-81. doi: 10.1016/j.virusres.2015.11.014. Epub 2015 Nov 15.

5.

Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Wiley CA, Bhardwaj N, Ross TM, Bissel SJ.

Brain Pathol. 2015 Sep;25(5):634-50. doi: 10.1111/bpa.12281. Review.

6.

Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.

Fischer WA 2nd, Chason KD, Brighton M, Jaspers I.

Vaccine. 2014 Mar 26;32(15):1761-7. doi: 10.1016/j.vaccine.2013.12.069. Epub 2014 Jan 30.

7.

Model-based simulation and prediction of an antiviral strategy against influenza A infection.

Hur KY, Moon JY, Kim SH, Yoo JY.

PLoS One. 2013 Jul 9;8(7):e68235. doi: 10.1371/journal.pone.0068235. Print 2013.

8.

Modeling within-host dynamics of influenza virus infection including immune responses.

Pawelek KA, Huynh GT, Quinlivan M, Cullinane A, Rong L, Perelson AS.

PLoS Comput Biol. 2012;8(6):e1002588. doi: 10.1371/journal.pcbi.1002588. Epub 2012 Jun 28.

9.

Macroevolutionary Immunology: A Role for Immunity in the Diversification of Animal life.

Loker ES.

Front Immunol. 2012 Mar 12;3:25. doi: 10.3389/fimmu.2012.00025. eCollection 2012 Mar 12.

10.

Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection.

Hsu AC, Parsons K, Barr I, Lowther S, Middleton D, Hansbro PM, Wark PA.

PLoS One. 2012;7(3):e32947. doi: 10.1371/journal.pone.0032947. Epub 2012 Mar 2.

11.

Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia.

Tuvim MJ, Gilbert BE, Dickey BF, Evans SE.

PLoS One. 2012;7(1):e30596. doi: 10.1371/journal.pone.0030596. Epub 2012 Jan 27.

12.

Human Metapneumovirus: lessons learned over the first decade.

Schildgen V, van den Hoogen B, Fouchier R, Tripp RA, Alvarez R, Manoha C, Williams J, Schildgen O.

Clin Microbiol Rev. 2011 Oct;24(4):734-54. doi: 10.1128/CMR.00015-11. Review.

13.

Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice.

Seo SU, Kwon HJ, Ko HJ, Byun YH, Seong BL, Uematsu S, Akira S, Kweon MN.

PLoS Pathog. 2011 Feb;7(2):e1001304. doi: 10.1371/journal.ppat.1001304. Epub 2011 Feb 24.

14.

Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells.

Ocaña-Macchi M, Bel M, Guzylack-Piriou L, Ruggli N, Liniger M, McCullough KC, Sakoda Y, Isoda N, Matrosovich M, Summerfield A.

J Virol. 2009 Dec;83(24):12947-55. doi: 10.1128/JVI.00468-09. Epub 2009 Oct 7.

15.

Innate immunity to influenza virus: implications for future therapy.

White MR, Doss M, Boland P, Tecle T, Hartshorn KL.

Expert Rev Clin Immunol. 2008 Jul 1;4(4):497-514.

16.

Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus.

Gabriel G, Klingel K, Planz O, Bier K, Herwig A, Sauter M, Klenk HD.

Am J Pathol. 2009 Sep;175(3):1178-86. doi: 10.2353/ajpath.2009.090339. Epub 2009 Aug 21.

17.
18.

Augmented lung inflammation protects against influenza A pneumonia.

Tuvim MJ, Evans SE, Clement CG, Dickey BF, Gilbert BE.

PLoS One. 2009;4(1):e4176. doi: 10.1371/journal.pone.0004176. Epub 2009 Jan 12.

19.

Current and future antiviral therapy of severe seasonal and avian influenza.

Beigel J, Bray M.

Antiviral Res. 2008 Apr;78(1):91-102. doi: 10.1016/j.antiviral.2008.01.003. Epub 2008 Feb 4. Review.

20.

Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.

Dittmann J, Stertz S, Grimm D, Steel J, García-Sastre A, Haller O, Kochs G.

J Virol. 2008 Apr;82(7):3624-31. doi: 10.1128/JVI.01753-07. Epub 2008 Jan 16.

Supplemental Content

Support Center